hla dr ab Search Results


93
Elabscience Biotechnology anti human hla dr
Anti Human Hla Dr, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hla+dr+ab/APC+Anti-Human+HLA-DR+Antibody/pmc11699128-301-37-39
Average 93 stars, based on 1 article reviews
anti human hla dr - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Elabscience Biotechnology fitc anti human hla dr
Fitc Anti Human Hla Dr, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hla+dr+ab/FITC+Anti-Human+HLA-DR+Antibody/pm41578166-106-20-27
Average 94 stars, based on 1 article reviews
fitc anti human hla dr - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

91
Elabscience Biotechnology hla dr
<t>HLA-DR</t> expression in monocyte. The mean fluorescence intensity (MFI) of HLA-DR was determined in basal CD14pos cells after 20 h of T. cruzi lysate (Tc) stimulation or fenofibrate (Tc + Fen) treatment. Monocytes were selected based on FSC and SSC. After excluding doublets and debris, live cells were selected, monocytes were classified by CD14 positive staining. The mean fluorescence intensity (MFI) of HLA-DR was calculated both in total monocytes (A) . It shows the mean fluorescence intensity (MFI) of CD14pos/HLA-DRpos monocytes in healthy (HI) (B) , asymptomatic (Asy) (C) and chronic Chagas disease (CHD) patients (D) , where each patient is represented by a circle. The results are shown as the mean of the experiments ± SEM. These data were analyzed by fitting a mixed effect model with a Tukey post-hoc test.
Hla Dr, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hla+dr+ab/PE%2FCyanine7+Anti-Human+HLA-DR+Antibody/pmc08963737-94-31-33
Average 91 stars, based on 1 article reviews
hla dr - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

94
Elabscience Biotechnology e ab f1111d
<t>HLA-DR</t> expression in monocyte. The mean fluorescence intensity (MFI) of HLA-DR was determined in basal CD14pos cells after 20 h of T. cruzi lysate (Tc) stimulation or fenofibrate (Tc + Fen) treatment. Monocytes were selected based on FSC and SSC. After excluding doublets and debris, live cells were selected, monocytes were classified by CD14 positive staining. The mean fluorescence intensity (MFI) of HLA-DR was calculated both in total monocytes (A) . It shows the mean fluorescence intensity (MFI) of CD14pos/HLA-DRpos monocytes in healthy (HI) (B) , asymptomatic (Asy) (C) and chronic Chagas disease (CHD) patients (D) , where each patient is represented by a circle. The results are shown as the mean of the experiments ± SEM. These data were analyzed by fitting a mixed effect model with a Tukey post-hoc test.
E Ab F1111d, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hla+dr+ab/PE+Anti-Human+HLA-DR+Antibody/pmc12794431-14-8-6
Average 94 stars, based on 1 article reviews
e ab f1111d - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Becton Dickinson purified azide/low endotoxin anti–hla-dr ab
<t>HLA-DR</t> expression in monocyte. The mean fluorescence intensity (MFI) of HLA-DR was determined in basal CD14pos cells after 20 h of T. cruzi lysate (Tc) stimulation or fenofibrate (Tc + Fen) treatment. Monocytes were selected based on FSC and SSC. After excluding doublets and debris, live cells were selected, monocytes were classified by CD14 positive staining. The mean fluorescence intensity (MFI) of HLA-DR was calculated both in total monocytes (A) . It shows the mean fluorescence intensity (MFI) of CD14pos/HLA-DRpos monocytes in healthy (HI) (B) , asymptomatic (Asy) (C) and chronic Chagas disease (CHD) patients (D) , where each patient is represented by a circle. The results are shown as the mean of the experiments ± SEM. These data were analyzed by fitting a mixed effect model with a Tukey post-hoc test.
Purified Azide/Low Endotoxin Anti–Hla Dr Ab, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hla+dr+ab/purified+azide+low+endotoxin+anti+hla+dr+ab/pm27481844-92-18-20
Average 90 stars, based on 1 article reviews
purified azide/low endotoxin anti–hla-dr ab - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson quantum red-conjugated anti-hla-dr ab
<t>HLA-DR</t> expression in monocyte. The mean fluorescence intensity (MFI) of HLA-DR was determined in basal CD14pos cells after 20 h of T. cruzi lysate (Tc) stimulation or fenofibrate (Tc + Fen) treatment. Monocytes were selected based on FSC and SSC. After excluding doublets and debris, live cells were selected, monocytes were classified by CD14 positive staining. The mean fluorescence intensity (MFI) of HLA-DR was calculated both in total monocytes (A) . It shows the mean fluorescence intensity (MFI) of CD14pos/HLA-DRpos monocytes in healthy (HI) (B) , asymptomatic (Asy) (C) and chronic Chagas disease (CHD) patients (D) , where each patient is represented by a circle. The results are shown as the mean of the experiments ± SEM. These data were analyzed by fitting a mixed effect model with a Tukey post-hoc test.
Quantum Red Conjugated Anti Hla Dr Ab, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hla+dr+ab/quantum+red+conjugated+anti+hla+dr+ab/pm11123353-130-23-34
Average 90 stars, based on 1 article reviews
quantum red-conjugated anti-hla-dr ab - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson anti-human hla-dr-fitc (555811, rrid: ab_396145 )
<t>HLA-DR</t> expression in monocyte. The mean fluorescence intensity (MFI) of HLA-DR was determined in basal CD14pos cells after 20 h of T. cruzi lysate (Tc) stimulation or fenofibrate (Tc + Fen) treatment. Monocytes were selected based on FSC and SSC. After excluding doublets and debris, live cells were selected, monocytes were classified by CD14 positive staining. The mean fluorescence intensity (MFI) of HLA-DR was calculated both in total monocytes (A) . It shows the mean fluorescence intensity (MFI) of CD14pos/HLA-DRpos monocytes in healthy (HI) (B) , asymptomatic (Asy) (C) and chronic Chagas disease (CHD) patients (D) , where each patient is represented by a circle. The results are shown as the mean of the experiments ± SEM. These data were analyzed by fitting a mixed effect model with a Tukey post-hoc test.
Anti Human Hla Dr Fitc (555811, Rrid: Ab 396145 ), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hla+dr+ab/antihuman+hla+dr+fitc++555811++rrid++ab+396145+/pmc10139961-116-10-40
Average 90 stars, based on 1 article reviews
anti-human hla-dr-fitc (555811, rrid: ab_396145 ) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson alexa fluor 700 anti-human hla-dr ab
<t>HLA-DR</t> expression in monocyte. The mean fluorescence intensity (MFI) of HLA-DR was determined in basal CD14pos cells after 20 h of T. cruzi lysate (Tc) stimulation or fenofibrate (Tc + Fen) treatment. Monocytes were selected based on FSC and SSC. After excluding doublets and debris, live cells were selected, monocytes were classified by CD14 positive staining. The mean fluorescence intensity (MFI) of HLA-DR was calculated both in total monocytes (A) . It shows the mean fluorescence intensity (MFI) of CD14pos/HLA-DRpos monocytes in healthy (HI) (B) , asymptomatic (Asy) (C) and chronic Chagas disease (CHD) patients (D) , where each patient is represented by a circle. The results are shown as the mean of the experiments ± SEM. These data were analyzed by fitting a mixed effect model with a Tukey post-hoc test.
Alexa Fluor 700 Anti Human Hla Dr Ab, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hla+dr+ab/alexa+fluor+700+anti+human+hla+dr+ab/med_rxiv__2024__02__15__24302255-216-61-67
Average 90 stars, based on 1 article reviews
alexa fluor 700 anti-human hla-dr ab - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Verlag GmbH fluorescent anti-hla-dr-fnir ab
<t>HLA-DR</t> expression in monocyte. The mean fluorescence intensity (MFI) of HLA-DR was determined in basal CD14pos cells after 20 h of T. cruzi lysate (Tc) stimulation or fenofibrate (Tc + Fen) treatment. Monocytes were selected based on FSC and SSC. After excluding doublets and debris, live cells were selected, monocytes were classified by CD14 positive staining. The mean fluorescence intensity (MFI) of HLA-DR was calculated both in total monocytes (A) . It shows the mean fluorescence intensity (MFI) of CD14pos/HLA-DRpos monocytes in healthy (HI) (B) , asymptomatic (Asy) (C) and chronic Chagas disease (CHD) patients (D) , where each patient is represented by a circle. The results are shown as the mean of the experiments ± SEM. These data were analyzed by fitting a mixed effect model with a Tukey post-hoc test.
Fluorescent Anti Hla Dr Fnir Ab, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hla+dr+ab/fluorescent+anti+hla+dr+fnir+ab/pm26678013-80-41-31
Average 90 stars, based on 1 article reviews
fluorescent anti-hla-dr-fnir ab - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson antihuman leukocyte antigen (hla)-dr-peridinin chlorophyll
The semi-mature phenotype and tolerogenic messenger RNA (mRNA) expression profile of tolerance-inducing dendritic cells (TolDCs) was not affected by mRNA electroporation.
Antihuman Leukocyte Antigen (Hla) Dr Peridinin Chlorophyll, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hla+dr+ab/antihuman+leukocyte+antigen+dr++hla+dr++ab/pmc05778265-82-21-26
Average 90 stars, based on 1 article reviews
antihuman leukocyte antigen (hla)-dr-peridinin chlorophyll - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Verlag GmbH anti-hla-dr-fnir ab
The semi-mature phenotype and tolerogenic messenger RNA (mRNA) expression profile of tolerance-inducing dendritic cells (TolDCs) was not affected by mRNA electroporation.
Anti Hla Dr Fnir Ab, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hla+dr+ab/anti+hla+dr+fnir+ab/pm26678013-45-16-3
Average 90 stars, based on 1 article reviews
anti-hla-dr-fnir ab - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Ozyme Inc anti-hla-dr-af700 ab
Behavior of LCs at the site of vaccination. ( a ) <t>HLA-DR</t> labeled LC network was visualized by in vivo fibered confocal microscopy and ( b ) quantified at the site of injection. Kruskal-Wallis test. Ex vivo confocal videomicroscopy of HLA-DR-labeled LC, showing ( c ) LC morphology and ( d ) the variation of the LC number normalized to the cell number at the first time point (n = 3). Friedman test. ( e ) LC motility parameters were measured from three independent experiments. Each point represents one cell. Mann–Whitney test. ( f ) Ex vivo confocal videomicroscopy of the epidermis 24 h after vaccination with the auxoGTU ® -Luc-EGFP vector with EP. Arrow indicates APC displacement toward an antigen expressing cell. Dotted line shows a HLA-DR and EGFP co-stained LC. Data are presented as mean ± SD; * p < 0.05; *** p < 0.001; EP, electroporation.
Anti Hla Dr Af700 Ab, supplied by Ozyme Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hla+dr+ab/anti+hla+dr+af700+ab/pmc05482824-147-24-26
Average 90 stars, based on 1 article reviews
anti-hla-dr-af700 ab - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


HLA-DR expression in monocyte. The mean fluorescence intensity (MFI) of HLA-DR was determined in basal CD14pos cells after 20 h of T. cruzi lysate (Tc) stimulation or fenofibrate (Tc + Fen) treatment. Monocytes were selected based on FSC and SSC. After excluding doublets and debris, live cells were selected, monocytes were classified by CD14 positive staining. The mean fluorescence intensity (MFI) of HLA-DR was calculated both in total monocytes (A) . It shows the mean fluorescence intensity (MFI) of CD14pos/HLA-DRpos monocytes in healthy (HI) (B) , asymptomatic (Asy) (C) and chronic Chagas disease (CHD) patients (D) , where each patient is represented by a circle. The results are shown as the mean of the experiments ± SEM. These data were analyzed by fitting a mixed effect model with a Tukey post-hoc test.

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC

doi: 10.3389/fcimb.2021.785166

Figure Lengend Snippet: HLA-DR expression in monocyte. The mean fluorescence intensity (MFI) of HLA-DR was determined in basal CD14pos cells after 20 h of T. cruzi lysate (Tc) stimulation or fenofibrate (Tc + Fen) treatment. Monocytes were selected based on FSC and SSC. After excluding doublets and debris, live cells were selected, monocytes were classified by CD14 positive staining. The mean fluorescence intensity (MFI) of HLA-DR was calculated both in total monocytes (A) . It shows the mean fluorescence intensity (MFI) of CD14pos/HLA-DRpos monocytes in healthy (HI) (B) , asymptomatic (Asy) (C) and chronic Chagas disease (CHD) patients (D) , where each patient is represented by a circle. The results are shown as the mean of the experiments ± SEM. These data were analyzed by fitting a mixed effect model with a Tukey post-hoc test.

Article Snippet: PBMC were stained with LIVE/DEADTM fixable dye (Invitrogen) at room temperature for 15 min and labeled with the following antibodies at 4°C for 30 min: CD14 (#E-AB-F1209C, Elabscience), CD16 (#E-AB-F1005M, Elabscience), HLA-DR (#E-AB-F1111H, Elabscience), and CCR2 (#357209, Elabscience).

Techniques: Expressing, Fluorescence, Staining

HLA-DR expression in T. cruzi stimulated and fenofibrate treated monocyte subpopulations. The mean fluorescence intensity percentage of HLA-DR + cells was determined in PBMC stimulated or not with T. cruzi lysate (Tc) and treated or not with fenofibrate (Tc + Fen) after 20 h, according to CD14 and CD16 expression. It shows the mean fluorescence intensity (MFI) of classical (CD14high/CD16neg) (A) , intermediate (CD14high/CD16pos) (B) and non-classical (CD14low/CD16pos) (C) monocytes with HLA-DR + expression. The results are shown as the mean of the experiments ± SEM. These data were analyzed by fitting a mixed effect model with a Tukey post-hoc test.

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC

doi: 10.3389/fcimb.2021.785166

Figure Lengend Snippet: HLA-DR expression in T. cruzi stimulated and fenofibrate treated monocyte subpopulations. The mean fluorescence intensity percentage of HLA-DR + cells was determined in PBMC stimulated or not with T. cruzi lysate (Tc) and treated or not with fenofibrate (Tc + Fen) after 20 h, according to CD14 and CD16 expression. It shows the mean fluorescence intensity (MFI) of classical (CD14high/CD16neg) (A) , intermediate (CD14high/CD16pos) (B) and non-classical (CD14low/CD16pos) (C) monocytes with HLA-DR + expression. The results are shown as the mean of the experiments ± SEM. These data were analyzed by fitting a mixed effect model with a Tukey post-hoc test.

Article Snippet: PBMC were stained with LIVE/DEADTM fixable dye (Invitrogen) at room temperature for 15 min and labeled with the following antibodies at 4°C for 30 min: CD14 (#E-AB-F1209C, Elabscience), CD16 (#E-AB-F1005M, Elabscience), HLA-DR (#E-AB-F1111H, Elabscience), and CCR2 (#357209, Elabscience).

Techniques: Expressing, Fluorescence

The semi-mature phenotype and tolerogenic messenger RNA (mRNA) expression profile of tolerance-inducing dendritic cells (TolDCs) was not affected by mRNA electroporation.

Journal: Frontiers in Immunology

Article Title: Shuttling Tolerogenic Dendritic Cells across the Blood–Brain Barrier In Vitro via the Introduction of De Novo C–C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation

doi: 10.3389/fimmu.2017.01964

Figure Lengend Snippet: The semi-mature phenotype and tolerogenic messenger RNA (mRNA) expression profile of tolerance-inducing dendritic cells (TolDCs) was not affected by mRNA electroporation.

Article Snippet: The phenotype of DCs was characterized using the following fluorochrome-labeled mouse antihuman monoclonal antibodies: anti-CD83-fluorescein isothiocyanate (Life Technologies), anti-CD80-phycoerythrin (BD Pharmingen), antihuman leukocyte antigen (HLA)-DR-peridinin chlorophyll (BD Biosciences), anti-CD86-fluorescein isothiocyanate (BD Pharmingen), and anti-CCR5-phycoerythrin-cyanin 7.

Techniques: Expressing, Electroporation

Behavior of LCs at the site of vaccination. ( a ) HLA-DR labeled LC network was visualized by in vivo fibered confocal microscopy and ( b ) quantified at the site of injection. Kruskal-Wallis test. Ex vivo confocal videomicroscopy of HLA-DR-labeled LC, showing ( c ) LC morphology and ( d ) the variation of the LC number normalized to the cell number at the first time point (n = 3). Friedman test. ( e ) LC motility parameters were measured from three independent experiments. Each point represents one cell. Mann–Whitney test. ( f ) Ex vivo confocal videomicroscopy of the epidermis 24 h after vaccination with the auxoGTU ® -Luc-EGFP vector with EP. Arrow indicates APC displacement toward an antigen expressing cell. Dotted line shows a HLA-DR and EGFP co-stained LC. Data are presented as mean ± SD; * p < 0.05; *** p < 0.001; EP, electroporation.

Journal: Scientific Reports

Article Title: Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques

doi: 10.1038/s41598-017-04547-2

Figure Lengend Snippet: Behavior of LCs at the site of vaccination. ( a ) HLA-DR labeled LC network was visualized by in vivo fibered confocal microscopy and ( b ) quantified at the site of injection. Kruskal-Wallis test. Ex vivo confocal videomicroscopy of HLA-DR-labeled LC, showing ( c ) LC morphology and ( d ) the variation of the LC number normalized to the cell number at the first time point (n = 3). Friedman test. ( e ) LC motility parameters were measured from three independent experiments. Each point represents one cell. Mann–Whitney test. ( f ) Ex vivo confocal videomicroscopy of the epidermis 24 h after vaccination with the auxoGTU ® -Luc-EGFP vector with EP. Arrow indicates APC displacement toward an antigen expressing cell. Dotted line shows a HLA-DR and EGFP co-stained LC. Data are presented as mean ± SD; * p < 0.05; *** p < 0.001; EP, electroporation.

Article Snippet: Briefly, skin biopsies were performed 24 hours after the injection auxo-GTU ® -Luc-EGFP plasmid and 2 hours after the in vivo id injection of anti-HLA-DR-AF700 Ab (Ozyme, France).

Techniques: Labeling, In Vivo, Confocal Microscopy, Injection, Ex Vivo, MANN-WHITNEY, Plasmid Preparation, Expressing, Staining, Electroporation

Characterization of immune infiltrates in the skin after EP or DNA + EP. ( a ) Skin cell suspensions were first gated for their morphology and viability. The gating strategy is shown on the skin of immunized macaque. Four cell populations of interest were analyzed: DR+CD163+CD14+ (monocytes/macrophages), DR+CD163−CD14− (dendritic cells), DR−CD3+ (T lymphocytes) and DR−CD66+ (neutrophils). ( b ) Flow cytometry analysis of skin cell recruitment 24 h after vaccination (n = 5); cell number was normalized to absolute cell number after PBS injection. Friedman test. ( c ) Representative ex vivo confocal videomicroscopy images of HLA-DR labeled dermal APCs 24 h post-injection of DNA ± EP. ( d ) Analysis of dermal APC motility 24 h post-vaccination. Each point represents one cell (n = 3). Mann–Whitney test. Data are presented as mean ± SD; * p < 0.05; ** p < 0.01; *** p < 0.001; EP, electroporation.

Journal: Scientific Reports

Article Title: Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques

doi: 10.1038/s41598-017-04547-2

Figure Lengend Snippet: Characterization of immune infiltrates in the skin after EP or DNA + EP. ( a ) Skin cell suspensions were first gated for their morphology and viability. The gating strategy is shown on the skin of immunized macaque. Four cell populations of interest were analyzed: DR+CD163+CD14+ (monocytes/macrophages), DR+CD163−CD14− (dendritic cells), DR−CD3+ (T lymphocytes) and DR−CD66+ (neutrophils). ( b ) Flow cytometry analysis of skin cell recruitment 24 h after vaccination (n = 5); cell number was normalized to absolute cell number after PBS injection. Friedman test. ( c ) Representative ex vivo confocal videomicroscopy images of HLA-DR labeled dermal APCs 24 h post-injection of DNA ± EP. ( d ) Analysis of dermal APC motility 24 h post-vaccination. Each point represents one cell (n = 3). Mann–Whitney test. Data are presented as mean ± SD; * p < 0.05; ** p < 0.01; *** p < 0.001; EP, electroporation.

Article Snippet: Briefly, skin biopsies were performed 24 hours after the injection auxo-GTU ® -Luc-EGFP plasmid and 2 hours after the in vivo id injection of anti-HLA-DR-AF700 Ab (Ozyme, France).

Techniques: Flow Cytometry, Injection, Ex Vivo, Labeling, MANN-WHITNEY, Electroporation